1. Home
  2. CLDX vs PLSE Comparison

CLDX vs PLSE Comparison

Compare CLDX & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$27.36

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$14.20

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
PLSE
Founded
N/A
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.2B
IPO Year
2008
2016

Fundamental Metrics

Financial Performance
Metric
CLDX
PLSE
Price
$27.36
$14.20
Analyst Decision
Buy
Buy
Analyst Count
10
1
Target Price
$43.80
$22.00
AVG Volume (30 Days)
759.2K
176.8K
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,599,000.00
$86,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$19.70
$1,002.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.40
$12.56
52 Week High
$30.50
$25.00

Technical Indicators

Market Signals
Indicator
CLDX
PLSE
Relative Strength Index (RSI) 52.62 50.43
Support Level $27.51 $13.12
Resistance Level $28.79 $13.96
Average True Range (ATR) 1.34 0.64
MACD 0.04 0.23
Stochastic Oscillator 43.25 73.33

Price Performance

Historical Comparison
CLDX
PLSE

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: